Bluefish Pharmaceuticals AB Sustainability Reports
Bluefish Pharmaceuticals AB is a generic pharmaceutical company that develops, manufactures, and markets a robust portfolio of generic medications and consumer healthcare products across the European Union. The company specializes in therapeutic areas including oncology, central nervous system disorders, cardiology, and pain management.
Sector: Manufacturing
Country: Sweden
Exchange: Unlisted
LEI: 549300IEZCGMLCSCRR44
11 reports from 2019 to 2025
